David R. Witty

1.6k total citations
36 papers, 1.3k citations indexed

About

David R. Witty is a scholar working on Organic Chemistry, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, David R. Witty has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Organic Chemistry, 21 papers in Molecular Biology and 8 papers in Pharmaceutical Science. Recurrent topics in David R. Witty's work include Chemical Synthesis and Analysis (10 papers), Fluorine in Organic Chemistry (8 papers) and Carbohydrate Chemistry and Synthesis (8 papers). David R. Witty is often cited by papers focused on Chemical Synthesis and Analysis (10 papers), Fluorine in Organic Chemistry (8 papers) and Carbohydrate Chemistry and Synthesis (8 papers). David R. Witty collaborates with scholars based in United Kingdom, United States and Italy. David R. Witty's co-authors include George W. J. Fleet, Nigel G. Ramsden, Francis X. Wilson, Abraham Karpas, Gary S. Jacob, Paul W. Smith, Linda E. Fellows, Jong Chan Son, Thomas W. Rademacher and A.S. Tyms and has published in prestigious journals such as FEBS Letters, The Journal of Organic Chemistry and Tetrahedron.

In The Last Decade

David R. Witty

36 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David R. Witty United Kingdom 19 929 652 141 79 74 36 1.3k
Willie L. Whitter United States 13 1.0k 1.1× 1.1k 1.7× 228 1.6× 24 0.3× 43 0.6× 19 2.0k
Roger Wrigglesworth United Kingdom 20 631 0.7× 704 1.1× 127 0.9× 30 0.4× 21 0.3× 63 1.6k
G. F. Lundell United States 13 983 1.1× 767 1.2× 200 1.4× 33 0.4× 46 0.6× 22 1.6k
Paul J. Kling United States 13 833 0.9× 751 1.2× 217 1.5× 18 0.2× 40 0.5× 19 1.5k
Minoru Moriya Japan 18 564 0.6× 281 0.4× 105 0.7× 24 0.3× 318 4.3× 40 1.1k
Steven P. Tanis United States 24 711 0.8× 468 0.7× 101 0.7× 31 0.4× 13 0.2× 45 1.2k
Deborah J. Cerino United States 7 808 0.9× 687 1.1× 185 1.3× 17 0.2× 38 0.5× 8 1.3k
Daniel‐Henri Caignard France 24 945 1.0× 666 1.0× 139 1.0× 43 0.5× 249 3.4× 62 1.6k
Kak‐Shan Shia Taiwan 25 1.1k 1.2× 640 1.0× 282 2.0× 34 0.4× 8 0.1× 99 2.1k
David G. Barrett United States 17 366 0.4× 483 0.7× 176 1.2× 19 0.2× 14 0.2× 50 1.0k

Countries citing papers authored by David R. Witty

Since Specialization
Citations

This map shows the geographic impact of David R. Witty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Witty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Witty more than expected).

Fields of papers citing papers by David R. Witty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Witty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Witty. The network helps show where David R. Witty may publish in the future.

Co-authorship network of co-authors of David R. Witty

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Witty. A scholar is included among the top collaborators of David R. Witty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Witty. David R. Witty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hurov, Kristen E., Johanna Lahdenranta, Punit Upadhyaya, et al.. (2021). BT7480, a novel fully synthetic Bicycle tumor-targeted immune cell agonist™ (Bicycle TICA™) induces tumor localized CD137 agonism. Journal for ImmunoTherapy of Cancer. 9(11). e002883–e002883. 25 indexed citations
2.
Witty, David R., Giuseppe Alvaro, Gerard M.P. Giblin, et al.. (2020). Discovery of Vixotrigine: A Novel Use-Dependent Sodium Channel Blocker for the Treatment of Trigeminal Neuralgia. ACS Medicinal Chemistry Letters. 11(9). 1678–1687. 17 indexed citations
3.
Singh, Onkar, Anthony Shillings, Peter D. Craggs, et al.. (2013). Crystal structures of ASK1‐inhibtor complexes provide a platform for structure‐based drug design. Protein Science. 22(8). 1071–1077. 23 indexed citations
4.
Witty, David R., Mahmood Ahmed, & Tsu Tshen Chuang. (2009). Advances in the Design of 5-HT6 Receptor Ligands with Therapeutic Potential. Progress in medicinal chemistry. 48. 163–224. 25 indexed citations
5.
Ray, Alison M., Warren D. Hirst, Mahmood Ahmed, et al.. (2008). P4‐327: Effects of the novel 5‐HT6 SB‐742457 antagonist and the cholinesterase inhibitor donepezil in models of cognition. Alzheimer s & Dementia. 4(4S_Part_24). 1 indexed citations
6.
Hertzog, Donald L. & David R. Witty. (2007). Biphenyl Amides and Isosteres as MCH R1 Antagonists. Current Topics in Medicinal Chemistry. 7(15). 1455–1470. 3 indexed citations
7.
Witty, David R., John H. Bateson, Guillaume Hervieu, et al.. (2006). SAR of biphenyl carboxamide ligands of the human melanin-concentrating hormone receptor 1 (MCH R1): Discovery of antagonist SB-568849. Bioorganic & Medicinal Chemistry Letters. 16(18). 4865–4871. 12 indexed citations
8.
Witty, David R., John H. Bateson, Guillaume Hervieu, et al.. (2006). Discovery of potent and stable conformationally constrained analogues of the MCH R1 antagonist SB-568849. Bioorganic & Medicinal Chemistry Letters. 16(18). 4872–4878. 18 indexed citations
9.
Jarvest, Richard L., John M. Berge, Pamela Brown, et al.. (2004). Definition of the heterocyclic pharmacophore of bacterial methionyl tRNA synthetase inhibitors: potent antibacterially active non-quinolone analogues. Bioorganic & Medicinal Chemistry Letters. 14(15). 3937–3941. 44 indexed citations
10.
Kennedy, A. R., Jeannie F Todd, Waljit S. Dhillo, et al.. (2003). Effect of Direct Injection of Melanin‐Concentrating Hormone into the Paraventricular Nucleus: Further Evidence for a Stimulatory Role in the Adrenal Axis via SLC‐1. Journal of Neuroendocrinology. 15(3). 268–272. 70 indexed citations
11.
Coldham, Iain, et al.. (2000). One-Pot Synthesis of N,N’-Bisacylimidazolidines; Potential New Acyl Anion Equivalents. Synlett. 1996(11). 1109–1111. 3 indexed citations
12.
Coldham, Iain, et al.. (1998). N,N′-Bisacylimidazolidines from 1,2-Diamines. Synthesis. 1998(10). 1463–1466. 9 indexed citations
13.
Fleet, George W. J., Francis X. Wilson, Richard Storer, et al.. (1991). Oxetane nucleosides with fluorine and azide substitutents: nucleophilic displacements on an oxetane ring. Tetrahedron Letters. 32(13). 1675–1678. 23 indexed citations
14.
15.
Fleet, George W. J., Richard Storer, Christopher J. Wallis, et al.. (1990). Synthesis of the potent antiviral oxetane nucleoside epinoroxetanocin from D-lyxonolactone. Tetrahedron Asymmetry. 1(8). 527–530. 30 indexed citations
16.
Witty, David R., et al.. (1990). Ring contraction of 2-o-trifluoromethanesulphonates of α-hydroxy-γ-lactones to oxetane carboxylic esters. Tetrahedron Letters. 31(33). 4787–4790. 42 indexed citations
17.
Fleet, George W. J., Nigel G. Ramsden, & David R. Witty. (1989). A practical synthesis of deoxymannojirimycin and of (2s,3R,4R,5R)-3,4,5-trihydroxypipecolic acid from D-glucose. Tetrahedron. 45(1). 327–336. 41 indexed citations
18.
Fleet, George W. J., Nigel G. Ramsden, & David R. Witty. (1989). Practical synthesis of deoxymannojirimycin and mannonolactam from L-gulonolactone.. Tetrahedron. 45(1). 319–326. 101 indexed citations
19.
Fleet, George W. J., Abraham Karpas, Linda E. Fellows, et al.. (1988). Inhibition of HIV replication by amino‐sugar derivatives. FEBS Letters. 237(1-2). 128–132. 308 indexed citations
20.
Fleet, George W. J., Nigel G. Ramsden, & David R. Witty. (1988). Short syntheses of D-deoxymannojirimycin and D-mannonolactam from L-gulonolactone and of L-deoxymannojirimycin and L-mannonolactam from D-gulonolactone. Tetrahedron Letters. 29(23). 2871–2874. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Willie L. Whitter Breakdown of academic impact, for papers by Roger Wrigglesworth Breakdown of academic impact, for papers by G. F. Lundell Breakdown of academic impact, for papers by Paul J. Kling Breakdown of academic impact, for papers by Minoru Moriya Breakdown of academic impact, for papers by Steven P. Tanis Breakdown of academic impact, for papers by Deborah J. Cerino Breakdown of academic impact, for papers by Daniel‐Henri Caignard Breakdown of academic impact, for papers by Kak‐Shan Shia Breakdown of academic impact, for papers by David G. Barrett
Rankless by CCL
2026